- Editor's PickNicole Sinclair•14 hours ago
Pharmaceutical giant Mylan (MYL), which has recently dominated headlines over the skyrocketing 400% price increase of its allergy drug, made the decision on Monday to introduce a lower-priced generic EpiPen competitor. Above-average price inflation on Mylan’s EpiPen franchise is certainly nothing new. As Raymond James’ Elliot Wilbur pointed out: If you Google the term “EpiPen price increase(s),” you get over 120,000 hits from 2011 to just prior to this latest story breaking.
- Business Insider•12 hours ago
Sen. Elizabeth Warren (D-Massachusetts) has demanded that the CEO of drug company Mylan, Heather...
Valeant Pharmaceuticals International, Inc. (VRX)
NYSE - NYSE Real Time Price. Currency in USD
|Bid||28.90 x 500|
|Ask||28.91 x 700|
|Day's Range||28.83 - 30.35|
|52wk Range||18.55 - 245.82|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-9.89|
|Avg Vol (3m)||29,930,736|
|Dividend & Yield||0.00 (0.00%)|